The clinical trials began on June 18th and were conducted by Russia’s Gamalei Institute of Epidemiology and Microbiology. The first coronavirus vaccine trial has been successfully tested on volunteers.
Cases related to the Coronavirus pandemic and the resulting deaths have been increasing around the world encouraging countries to find a cure for the same as soon as possible. The clinical trials of the world's first coronavirus vaccine have been successfully completed in Russia. The Coronavirus outbreak that has caused the world to go under lockdown for almost 6 months resulting in over 12 million people being infected and over 500,000 killed this good news comes as a ray of hope.
The clinical trials of the world's first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University have been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, according to Russian news agency Sputnik, adding that the first group of volunteers would be discharged on 15 July and the second on 20 July.
The trials began on June 18th by the university for the vaccine which is produced by Russia’s Gamalei Institute of Epidemiology and Microbiology. The main objective of the test at this stage was to prove its safety on human health which has become successful according to Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University. Any further development regarding the complexity of the pandemic and the need for possible scaling up of production is being determined.
/socialketchup/media/agency_attachments/oTmmYmTemGaSn2TxEWbL.png)
Follow Us/socialketchup/media/post_banners/SxxefBAxNZ0Ft4ObvXSU.jpg)
/socialketchup/media/media_files/2024/10/29/5nWH2wX9bJ525bXgAc73.png)